Clinical Pharmacology of Carvedilol
Authors:
- 1 December 1999
- journal article
- other
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 4 (4) , 205-218
Abstract
Background: There is now a wealth of data supporting the use of beta-blockers in heart failure and the additional pharmacological properties of carvedilol are thought to play an important role in the therapeutic efficacy of carvedilol in this disease. Methods and Results: Carvedilol is licensed for the treatment of essential hypertension, chronic stable angina, and mild to moderate chronic heart failure. This article provides an up-to-date review of the clinical pharmacology of carvedilol, with particular emphasis on its clinical effects in heart failure. Conclusion: Carvedilol is a multiple-action neurohormonal antagonist that offers non selective beta-blockade, alpha-1 blockade, antioxidant, anti-ischemic mortality, and anti proliferative properties. In addition to reductions in hospitalization and mortality rates, benefits of carvedilol in heart failure include dramatic improvements in left ventricular function and other parameters of cardiac remodeling.Keywords
This publication has 66 references indexed in Scilit:
- Carvedilol Inhibits Endothelin-1 Biosynthesis in Cultured Human Coronary Artery Endothelial CellsJournal of Molecular and Cellular Cardiology, 1998
- Safety and efficacy of carvedilol in severe heart failureJournal of Cardiac Failure, 1997
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJACC, 1995
- A Risk-Benefit Assessment of Carvedilol in the Treatment of Cardiovascular DisordersDrug Safety, 1994
- Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Metabolism of carvedilol in manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Pharmacokinetics and Bioavailability of Carvedilol in Patients with Liver CirrhosisDrugs, 1988
- Therapeutic Benefits and Safety of Carvedilol in the Treatment of Renal HypertensionDrugs, 1988
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985